Skip to main content
. 2022 May 14;10(3):e00954. doi: 10.1002/prp2.954

FIGURE 5.

FIGURE 5

Ivermectin significantly augments in vivo efficacy of sorafenib. Mice body weight (A) and tumor size (B) in group (n = 10) receiving vehicle, group (n = 10) receiving 5mg/kg oral ivermectin, group (n = 10) receiving 2.5 kg/mg oral sorafenib, group (n = 10) receiving combination of ivermectin and sorafenib. *p < 0.05, compared to sorafenib